Profile of sales and notifications of suspected adverse events related to hydroxychloroquine and chloroquine during the COVID-19 pandemic. Research, Society and Development, [S. l.], v. 12, n. 2, p. e15112240021, 2023. DOI: 10.33448/rsd-v12i2.40021. Disponível em: https://ojs34.rsdjournal.org/index.php/rsd/article/view/40021. Acesso em: 28 jun. 2025.